Research Down Syndrome Announces 2011/2012 Grant Awards

Oct 26, 2011, 14:08 ET from Research Down Syndrome

CHICAGO, Oct. 26, 2011 /PRNewswire-USNewswire/ -- Research Down Syndrome (RDS) has announced funding for six grants to support Down syndrome cognitive research.  This field of research has seen tremendous progress in recent years, including the September 2011 announcement by Roche of a human clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with Down syndrome.

Research Down Syndrome, among the leading sources of private funding for Down syndrome related cognitive research,  prioritizes funding towards programs with a high probability of readily contributing to the development of safe and effective therapies.  Continued private donations are needed to support the constantly expanding research efforts that will lead to potential medical treatments. The 2011/2012 RDS Research Grants include:

Johns Hopkins University School of Medicine:  RDS Research Center Grant entitled "A Down Syndrome Virtual Center for Basic and Translational Studies-Cognition and Therapy in Down Syndrome."

University of California, San Diego School of Medicine:  RDS Research Center Grant entitled "Deciphering the Genetic and Mechanistic Bases for Cognitive Deficits in People with Down Syndrome: Pursuing High Priority Projects to Accelerate Development of Effective Treatments."

Stanford University School of Medicine:  RDS Innovation Research Grant entitled "Reducing Cognitive Disability in Down Syndrome-Exploration of the Mechanisms of Hippocampal Dysfunction and Pharmacotherapy."

University of Arizona:  RDS Innovation Research Grant entitled "The Neuropsychology of Down Syndrome."

University of Texas, Austin:  RDS Innovation Research Pilot Grant entitled "Molecular analysis of proneurogenic, neuroprotective drugs on prevention of APP-induced neurodegeneration in a model of Down syndrome."

VA Palo Alto Health Care System: RDS Innovation Research Pilot Grant entitled "Improving Beta-adrenergic Signaling in the Treatment of Cognitive Dysfunction, an in vivo Study in the Ts65Dn Mouse Model of Down Syndrome."

Detailed information on these grants can be found at

About Research Down Syndrome

Research Down Syndrome (RDS) is among the leading sources of private funding for Down syndrome related cognitive research.  RDS supports and funds Down syndrome cognitive research conducted at leading research institutions that are studying the basis of the intellectual impairments associated with Down syndrome - including Johns Hopkins University; Stanford University; University of Arizona; University of California, San Diego; University of Colorado;  University of Texas, Austin; and VA Palo Alto Health Care System.  Research Down Syndrome is a legal corporate entity, and is a 501(c) (3) nonprofit organization designated by the Internal Revenue Code.  For more information, go to, or contact RDS: or 877.863.2121.

Available Topic Expert: For information on the listed expert, click appropriate link.
Robert C. Schoen, Ph.D.

SOURCE Research Down Syndrome